Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Camp4 Therapeutics (CAMP) Capital Expenditures (2023 - 2025)

Historic Capital Expenditures for Camp4 Therapeutics (CAMP) over the last 3 years, with Q1 2025 value amounting to $279000.0.

  • Camp4 Therapeutics' Capital Expenditures rose 8476.82% to $279000.0 in Q1 2025 from the same period last year, while for Sep 2025 it was $542000.0, marking a year-over-year increase of 2874.11%. This contributed to the annual value of $441000.0 for FY2024, which is 3495.58% down from last year.
  • According to the latest figures from Q1 2025, Camp4 Therapeutics' Capital Expenditures is $279000.0, which was up 8476.82% from $263000.0 recorded in Q4 2024.
  • Camp4 Therapeutics' 5-year Capital Expenditures high stood at $279000.0 for Q1 2025, and its period low was $27000.0 during Q2 2024.
  • Its 3-year average for Capital Expenditures is $192600.0, with a median of $243000.0 in 2023.
  • In the last 5 years, Camp4 Therapeutics' Capital Expenditures skyrocketed by 823.05% in 2024 and then surged by 8476.82% in 2025.
  • Camp4 Therapeutics' Capital Expenditures (Quarter) stood at $243000.0 in 2023, then rose by 8.23% to $263000.0 in 2024, then grew by 6.08% to $279000.0 in 2025.
  • Its last three reported values are $279000.0 in Q1 2025, $263000.0 for Q4 2024, and $27000.0 during Q2 2024.